Ignite Creation Date:
2025-12-26 @ 1:18 PM
Ignite Modification Date:
2026-02-22 @ 4:14 PM
Study NCT ID:
NCT04539106
Status:
COMPLETED
Last Update Posted:
2020-09-04
First Post:
2020-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Ranibizumab in Recurrent ROP
Sponsor:
Ameera Gamal Abdelhameed
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
intravitreal Ranibizumab reinj
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None